Lv1
40 积分 2025-06-06 加入
Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial
28天前
已完结
Development and Clinical Indications of Cetuximab
1个月前
已完结
Progress of ATM inhibitors: opportunities and challenges
1个月前
已完结
Targeting ATR in patients with cancer
1个月前
已完结
DNA Damage Repair Inhibitors—Combination Therapies
2个月前
已完结
DNA damage response inhibitors in cancer therapy: lessons from the past, current status and future implications
2个月前
已完结
Targeting Replication Stress and Chemotherapy Resistance with a Combination of Sacituzumab Govitecan and Berzosertib: A Phase I Clinical Trial
2个月前
已完结
Pan-cancer antagonistic inhibition pattern of ATM-driven G2/M checkpoint pathway vs other DNA repair pathways
2个月前
已完结
Enhancing the anti-tumor response by combining DNA damage repair inhibitors in the treatment of solid tumors
2个月前
已完结
皖公网安备34019202002308
